phocytes were depleted of T-cells, B-cells, and EA-and EAC-(antibody-coated bovine erythrocytes and bovine erythrocytes coated with rabbit anti-bovine antibodies and C5-deficient mouse serum, respectively) rosette-forming cells by differential centrifugation. Column passage was used as an alternative to depletion of B-cells and F(c)-receptor-positive cells. Antibody-dependent, cell-mediated cytotoxicity was found to be associated with nonphagocytic cells carrying low-avidity F(c) receptors. Some of these had surface immunoglobulin; others lacked both B-and T-cell markers. Low levels of killing were found without addition of anti-herpes antibody to the test system, and this killing seemed to depend on cells belonging to the same subpopulation as the antibody-dependent effector cells.
Lymphoid cells from humans or other animals sensitized in vivo or in vitro against cellbound antigens acquire the ability to lyse cells carrying these antigens in vitro (1, 13) . This cytotoxic potential has been ascribed to T-cells (1) . On the other hand, target cells coated with antibodies against surface determinants are attacked by lymphoid cells from nonsensitized individuals (11) . This reaction runs devoid of complement in the assay. The types of effector cells (K-cell) involved in this antibody-dependent, cell-mediated cytotoxicity (ADCC) system vary, depending, among other things, on the target and the class of antibody bound. Monocytes, neutrophil granulocytes, T-cells, B-cells, and "null" cells have been shown to be responsible in different situations (2-4, 6, 8, 10, 14, 17, 19, 20) .
In the previous paper (12) , evidence was presented that cell-mediated cytotoxicity to herpes simplex virus type 1 (HSV-1)-infected fibroblasts in humans belongs to the ADCC kind of reaction. The study reported below was undertaken to characterize the effector cells involved.
MATERIALS AND METHODS
Freshly drawn blood from eight healthy human donors was used. Heparinized blood (20 IU/ml) or buffy-coat cells (obtained after centrifugation) were layered on Ficoll-Isopaque, and the lymphocyte-rich fraction was recovered and washed seven times. As described in the previous paper (12), it does not matter whether the lymphocytes were collected from donors previously sensitized to HSV or not, as the intensive wash removes the difference between the lymphocytes from the two groups. Parker's medium (TC 199) with 5% heat-inactivated fetal calf serum was used throughout, unless otherwise stated.
Phagocytic cells. Phagocytic cells were removed by combining surface adherence and iron phagocytosis (5 mg of carbonyl iron per ml) in Falcon flasks at 37°C for 30 to 45 min. Treatment with a magnet in three passages was used to clean the suspension of phagocytic cells and iron.
Latex phagocytosis and/or cytoplasmatic staining with acridine orange were used as macrophage markers.
T-cells. T-cells were visualized in the test suspension as E-rosette-forming cells, using 2-aminoethylisothiouronium bromide-treated sheep erythrocytes (9) . Rosette formation was performed by incubation of the lymphocyte-sheep erythrocyte mixture at 37°C for 15 min, followed by incubation at 4°C overnight. E-rosette percentages were determined after addition of acridine orange, followed by suspension of the pellet by gently tipping the tube. A fluorescence microscope equipped with phase-contrast visible light was used. No less than 200 cells were counted when scorings were performed.
Suspensions of E-rosette mixtures without acridine orange, but with 25% fetal calf serum added, were depleted of T-cells by placing Ficoll-Isopaque underneath the mixture, followed by centrifugation (400 x g) at room temperature for 30 min. Interphase cells were harvested and washed twice. Ig+ cells were removed on Ficoll-Isopaque gradients after rosette formation with autologous erythrocytes coated with polyvalent rabbit anti-human Ig (Dakopatts) by the CrCl3 method (5) (anti-Ig rosettes). Erythrocytes from the blood donor were recovered from the bottom of the initial Ficoll-Isopaque flotation. They were washed five times in normal saline, and an equal volume of undiluted solution (1 mg of Ig per ml) was added to the packed cells. CrCl3 was added during stirring, and the mixture was left at room temperature for 10 min, followed by four washes in phosphate-buffered saline or culture medium. Prior to the main coupling, test coupling using smaller volumes of cells and antibodies with different dilutions of CrCl3 in NaCl was performed. This was done to ensure that subagglutinating conditions (5) would be obtained during each main coupling.
Anti-Ig rosettes were produced by mixing lymphocytes and coupled erythrocytes in a ratio of 1:50, followed by sedimentation in a centrifuge (5 min, 200 x g). After a further 5 to 10 min at room temperature, the pellet was resuspended rather vigorously, using a Pasteur pipette. Rosettes were determined by addition of acridine orange and read as described for T-lymphocytes. Fetal calf serum was added to the suspension to be depleted of B-cells to a concentration of 25%, and then the procedure was as described above for T-cells.
Scoring of rosette-forming cells by counting the anti-Ig-coupled erythrocytes was used as an alternative to, or together with, immunofluorescence to determine the B-cell percentages in the lymphocyte suspensions.
F(c)-receptor-carrying cells. F(c)-receptor-carrying cells were detected and sometimes removed after rosette formation with antibody-coated bovine erythrocytes (EA) (hyperimmune rabbit anti-bovine erythrocyte antibodies in subagglutinating doses). The conditions for rosette formation and depletion of rosettes and free EA were as described for anti-Ig rosettes.
C3-receptor-carrying cells. C3-receptor-carrying cells were detected and/or removed after rosette formation with bovine erythrocytes coated with rabbit anti-bovine antibodies and C5-deficient mouse serum (obtained from AKR mice) (EAC). The dose of antibody used to coat erythrocytes was below the level at which F(c) rosettes would be formed. Rosettes using heat-inactivated (I) AKR serum as the "complement" source (EAC I) were used as controls and resulted in less than 1% rosette-forming lym- This type of column and its use in B-cell depletion has been described by others (18) . The second column (type II) was made up of a matrix of Sepharose macrobeads (kindly supplied by Pharmacia), which had been activated by cyanogen bromide according to standard methods. To this matrix was coupled anti-human Ig (prepared as above) that had been heat-aggregated at 63°C for 1 h. Approximately 15 mg was bound per 15 ml of packed beads. Cells were passed through the column at a flow rate of 2 ml/min at 4°C. Attempts to eluate bound cells were relatively unsuccessful and will not be further commented on here.
Cytotoxic assay. Allogeneic, or sometimes autologous, human fibroblasts originating from skin biopsies were infected with 0.1 plaque-forming unit of HSV-1, strain Maclntyre, per cell. After 48 h, when about one-third of the cells showed clear cytopathic effect, the cells were trypsinized, washed, and labeled with 51Cr according to standard methods, to serve as specific target cells.
Fibroblasts, 104 per reaction tube (Nunc plastic, 11 by 70 mm), were incubated with anti-HSV-1-containing serum in a fixed dilution (1:20) and with effector cells ranging in amounts from 0.6 x 105 to 106 in a volume of 1 ml. After incubation at 37°C for 16 to 18 h, 0.7 ml of supernatant was harvested, and the emission of gamma rays was measured in a gamma counter. Noninfected target fibroblasts were run in parallel as controls. The percentage of killing is expressed as [(test -spontaneous release)/(maximum -spontaneous release)] x 100, essentially as previously described (13) . Specific killing, as used in the test, refers to the percentage of killed infected targets minus that of killed noninfected targets.
The antibody-containing serum used originated from two males and had titers of 16 in complement fixation assays.
RESULTS
Suspensions of lymphoid cells from healthy adult donors, washed free of autologous serum, were tested as effector cells against HSV-1-infected target cells with and without addition of serum containing antibodies against HSV. Different ratios of lymphocytes to target cells were used. Suspensions of lymphocytes depleted of monocytes and granulocytes were compared with undepleted suspensions. The average content of phagocytes before depletion was 15.3%, and it was 0.8% after depletion. Figure 1 shows the results of these experiments. Although almost total depletion of phagocytic cells had been produced, ADCC (the upper points), produced by the resultant cell populations, occurred at an unaltered magnitude (no significant difference within the two groups at the same ratio). (Table 3) . In addition, it should be noted from Table 1 6:1
and Fig. 2 ADCC" had also been produced by the ADCCactive cell populations.
Finally, whether xenogeneic effector cells could function as K-cells in the system was tested. Using a fixed number of target cells and antibody dilution, it was found that mononuclear rat spleen cells did work, but that about 10 times more rat cells were required to obtain an isotope release equal to that produced by human lymphocytes. DISCUSSION In attempts to define the effector cells involved in the killing of HSV-1-infected target fibroblasts, the possibility that different cell types might possibly act in concert should be considered. The finding by others that cell-mediated immunity against HSV-1 virus can be detected by a lymphocyte transfonnation assay, which seems to be dependent on responding Tcells (16) If F(c)-receptor cells with the highest avidities were the active cells, as in a chicken erythrocyte ADCC system described (2), we would expect Ig antibody column purification and the rosette-forming method to be equally effective, as the high-avidity cells stick more firmly to the complexes on the column than do the lowavidity cells. However, the columns were not very effective in removing the active cells. Thus, our interpretation, as we offer it, is that the K-cells in the ADCC herpes system are a nonadherent, non-T-lymphocyte subpopulation with low-avidity F(c) receptors. Some of them are Ig+, whereas others must be termed "null" cells. K-cells from another species (rat) were also active, but a larger number of effector cells was needed.
Low levels of killing were obtained by effector cells without added anti-HSV antibody. The level of this killing varied in different lymphocyte suspensions, but it indicated that the same effector cells were active in both the "non"-ADCC and the ADCC. Whether this might be due to the presence of small amounts of antibodies in fetal calf serum combining with the HSV-infected target cells, or is consequent to the production of small amounts of antibody by the effector cells during the incubation period, remains to be determined. On the other hand, in this system the results exclude the possibility of a non-antibody-dependent killer process caused by T-cells.
The effector cells involved in ADCC have been identified in a number of studies, in different species and using different targets and antibodies. Quite marked differences exist in that adherent and phagocytic cells (3, 20) , B-cells (4, 14) , "null" cells with F(c)-receptors (17, 19) , nonadherent monocytes (6), and even T-cells (10) have been identified as killers in various studies. In situations where virus-infected target cells have been used, pure cell-mediated killing by T-cells has been shown to be the effector mechanism in the killing of rubellainfected cells (15) , whereas mumps-infected targets are attacked by an antibody-dependent non-T-cell (7). Thus, it is difficult to predict the outcome when switching to a system, such as the present one, not previously analyzed.
It is evident from our study reported here, and from the preceding one, that effector cells with similar potencies, and presumably in similar amounts, are present in individuals whether they are HSV seronegative or HSV seropositive. Whether any fluctuations can be detected in relation to acute or recurrent herpetic infections remains to be tested (work in progress).
